已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Independence of Lipoprotein(a) and Low-Density Lipoprotein Cholesterol–Mediated Cardiovascular Risk: A Participant-Level Meta-Analysis

医学 内科学 四分位数 动脉粥样硬化性心血管疾病 危险系数 他汀类 瑞舒伐他汀 比例危险模型 脂蛋白(a) 心脏病学 脂蛋白 安慰剂 胆固醇 内分泌学 置信区间 疾病 替代医学 病理
作者
Harpreet S. Bhatia,Simon Wandel,Peter Willeit,Anastasia Lesogor,Keith Bailey,Paul M. Ridker,Paul J. Nestel,R. J. Simes,Andrew Tonkin,Gregory G. Schwartz,Helen M. Colhoun,Christoph Wanner,Sotirios Tsimikas
出处
期刊:Circulation [Lippincott Williams & Wilkins]
被引量:1
标识
DOI:10.1161/circulationaha.124.069556
摘要

BACKGROUND: Low-density lipoprotein cholesterol (LDL-C) and lipoprotein(a) (Lp[a]) levels are independently associated with atherosclerotic cardiovascular disease (ASCVD). However, the relationship between Lp(a) level, LDL-C level, and ASCVD risk at different thresholds is not well defined. METHODS: A participant-level meta-analysis of 27 658 participants enrolled in 6 placebo-controlled statin trials was performed to assess the association of LDL-C and Lp(a) levels with risk of fatal or nonfatal coronary heart disease events, stroke, or any coronary or carotid revascularization (ASCVD). The multivariable-adjusted association between baseline Lp(a) level and ASCVD risk was modeled continuously using generalized additive models, and the association between baseline LDL-C level and ASCVD risk by baseline Lp(a) level by Cox proportional hazards models with random effects. The joint association between Lp(a) level and statin-achieved LDL-C level with ASCVD risk was evaluated using Cox proportional hazards models. RESULTS: Compared with an Lp(a) level of 5 mg/dL, increasing levels of Lp(a) were log-linearly associated with ASCVD risk in statin- and placebo-treated patients. Among statin-treated individuals, those with Lp(a) level >50 mg/dL (≈125 nmol/L) had increased risk across all quartiles of achieved LDL-C level and absolute change in LDL-C level. Even among those with the lowest quartile of achieved LDL-C level (3.1–77.0 mg/dL), those with Lp(a) level >50 mg/dL had greater ASCVD risk (hazard ratio, 1.38 [95% CI, 1.06–1.79]) than those with Lp(a) level ≤50 mg/dL. The greatest risk was observed with both Lp(a) level >50 mg/dL and LDL-C level in the fourth quartile (hazard ratio, 1.90 [95% CI, 1.46–2.48]). CONCLUSIONS: These findings demonstrate the independent and additive nature of Lp(a) and LDL-C levels for ASCVD risk, and that LDL-C lowering does not fully offset Lp(a)-mediated risk.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
学术小白发布了新的文献求助10
1秒前
Frost发布了新的文献求助10
2秒前
枝挽发布了新的文献求助10
3秒前
香蕉觅云应助孟一采纳,获得10
4秒前
5秒前
6秒前
大模型应助WEE采纳,获得10
7秒前
Anna发布了新的文献求助20
7秒前
qyn1234566发布了新的文献求助30
9秒前
枝挽完成签到,获得积分20
10秒前
深情安青应助谢非凡采纳,获得10
10秒前
二猫完成签到,获得积分10
11秒前
小汪发布了新的文献求助10
15秒前
qyn1234566完成签到,获得积分10
15秒前
15秒前
梦里繁花完成签到,获得积分10
16秒前
16秒前
彭于晏应助学术小白采纳,获得10
17秒前
17秒前
18秒前
田様应助momo采纳,获得10
18秒前
科研通AI2S应助阿峰采纳,获得10
18秒前
孟一发布了新的文献求助10
21秒前
21秒前
ersan发布了新的文献求助10
21秒前
YHJ发布了新的文献求助10
21秒前
谢非凡发布了新的文献求助10
22秒前
xe发布了新的文献求助10
23秒前
SciGPT应助淡淡东蒽采纳,获得10
23秒前
wualexandra完成签到,获得积分10
24秒前
GGbond完成签到 ,获得积分10
25秒前
今后应助huang采纳,获得10
25秒前
研友_nxwmeL完成签到,获得积分10
25秒前
27秒前
情怀应助karry采纳,获得10
28秒前
汉堡包应助刻苦念桃采纳,获得10
28秒前
忍蛙完成签到,获得积分10
28秒前
小蘑菇应助yc12138采纳,获得10
29秒前
旦超完成签到,获得积分10
30秒前
31秒前
高分求助中
Annie Ernaux: De la perte au corps glorieux 600
Petrology and Plate Tectonics,2025 500
A revision of Limenitis helmanni and its related species (Nymphalidae) from Central and South China 400
Moore's Clinically Oriented Anatomy 10th Edition 400
Direct and Iterative Linear System Solvers 400
Cardiopulmonary Bypass and Mechanical Support: Principles and Practice, Fifth Edition 400
Circular Polar Constellations Providing Continuous Single or Multiple Coverage Above a Specified Latitude 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6774667
求助须知:如何正确求助?哪些是违规求助? 8498593
关于积分的说明 18107053
捐赠科研通 6070435
什么是DOI,文献DOI怎么找? 3015859
邀请新用户注册赠送积分活动 1992808
关于科研通互助平台的介绍 1973499